Moreover, LAT1 expression is significantly higher in breast cancer than in normal breast tissue and more obvious in advanced breast cancer, indicating that LAT1 can act as a potential therapeutic target (El Ansari et al., 2018). Here, SLC7A5 is linked to breast cancer.